GlassScriptPhysician profile
Amy L Simone
NPI 1003914714
$1,260.74
in general payments reported to CMS, 2019-2025
11 companies · $440 in 2025
The $440 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $147 · 2022: $191 · 2023: $183 · 2024: $300 · 2025: $440.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $922.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $922.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $297.41 | 2024-2025 | |
| Gilead Sciences, INC. | $208.01 | 2023-2024 | Livdelzi, Epclusa |
| Janssen Pharmaceuticals, INC | $145.23 | 2022-2025 | Spravato |
| Exact Sciences Corporation | $107.09 | 2025 | The Cologuard Plus Collection Kit |
| Axsome Therapeutics, INC. | $97.46 | 2023 | Auvelity |
| Horizon Therapeutics Plc | $96.37 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $96.21 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $91.57 | 2024 | Xifaxan |
| Novo Nordisk INC | $70.25 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $26.14 | 2021 | |
| Neurocrine Biosciences, INC. | $25.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Simone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.